BIOCHEMICAL MARKERS IN HUMAN BREAST CANCER
- 1 January 1977
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 309 (8003), 132-134
- https://doi.org/10.1016/s0140-6736(77)91719-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- PROGNOSTIC SIGNIFICANCE OF INAPPROPRIATE PRODUCTION OF PREGNANCY PROTEINS BY BREAST CANCERSThe Lancet, 1976
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- Biochemical Monitoring of Cancer: A ReviewAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1976
- Secretion of immunoreactive calcitonin by human breast carcinomas.BMJ, 1975
- Measurement of Serum Ferritin by Radioimmunoassay: Results in Normal Individuals and Patients With Breast Cancer 2JNCI Journal of the National Cancer Institute, 1975
- Biological markers in breast carcinoma.I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosidesCancer, 1975
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- Role of Serial Plasma C.E.A. Assays in Detection of Recurrent and Metastatic Colorectal CarcinomasBMJ, 1974
- Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial CarcinomaBMJ, 1972
- Natural History of Untreated Breast Cancer (1805-1933)BMJ, 1962